Evidence map›Paper›PMID 34713328›Full record

ArticleEuropean radiology2022

COVID-19 pneumonia imaging follow-up: when and how? A proposition from ESTI and ESR.

K Martini, A R Larici, M P Revel, B Ghaye, N Sverzellati, A P Parkar, A Snoeckx, N Screaton, J Biederer, H Prosch and 5 more

Open access · hybridAbstract read
In one paragraph

Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 10 countries.

K MartiniInstitute of Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. katharina.martini@usz.ch.ORCID http://orcid.org/0000-0002-2638-6832
A R LariciDepartment of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
M P RevelDepartment of Radiology, Cochin Hospital, Université de Paris, Paris, France.
B GhayeDepartment of Radiology, Cliniques Universitaires Saint Luc, Catholic University of Louvain, Brussels, Belgium.
N SverzellatiScienze Radiologiche, Department of Medicine and Surgery, University of Parma, Parma, Italy.
A P ParkarDepartment of Radiology, Haraldsplass Deaconess Hospital and Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
A SnoeckxDepartment of Radiology, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium.
N ScreatonDepartment of Radiology, Royal Papworth Hospital, Cambridge, UK.
J BiedererDepartment of Diagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany.
H ProschDepartment of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
M SilvaScienze Radiologiche, Department of Medicine and Surgery, University of Parma, Parma, Italy.
A BradyDepartment of Radiology, Mercy University Hospital, Cork, and University College Cork, Cork, Ireland.
F GleesonDepartment of Oncology, University of Oxford, Oxford, UK.
T FrauenfelderInstitute of Diagnostic and Interventional Radiology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
European Society of Thoracic Imaging (ESTI), the European Society of Radiology (ESR)
University Hospital of Zurich · CHUniversity of Parma · ITCliniques Universitaires Saint-Luc · BEHeidelberg University · DEMedical University of Vienna · ATPapworth Hospital · GBUniversità Cattolica del Sacro Cuore · ITUniversité Paris Cité · FRUniversity College Cork · IEUniversity of Antwerp · BEUniversity of Bergen · NOUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This document from the European Society of Thoracic Imaging (ESTI) and the European Society of Radiology (ESR) discusses the role of imaging in the long-term follow-up of COVID-19 patients, to define which patients may benefit from imaging, and what imaging modalities and protocols should be used. Insights into imaging features encountered on computed tomography (CT) scans and potential pitfalls are discussed and possible areas for future review and research are also included. KEY POINTS: • Post-COVID-19 pneumonia changes are mainly consistent with prior organizing pneumonia and are likely to disappear within 12 months of recovery from the acute infection in the majority of patients. • At present, with the longest series of follow-up examinations reported not exceeding 12 months, the development of persistent or progressive fibrosis in at least some individuals cannot yet be excluded. • Residual ground glass opacification may be associated with persisting bronchial dilatation and distortion, and might be termed "fibrotic-like changes" probably consistent with prior organizing pneumonia.

Indexed as

COVID-19PneumoniaRadiologyHumansLungTomography, X-Ray ComputedCOVID-19Diagnostic imagingFollow-upLungMultidetector computed tomography

Identifiers

PMID34713328
PMCPMC8553396
OpenAlexW3210818221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.